MyFinsight
Home
Blog
About
Contact
Download
Download image
Net proceeds from
sale of common stock
$6,553,209
Proceeds from sale of
common stock, related...
$3,000,000
Repayment from officer
$155,518
Net cash provided by
financing activities
$9,708,727
Net change in cash
$6,020,539
Canceled cashflow
$3,688,188
Stock-based compensation
expense
$5,290,329
Issuance of common stock
for services
$840,000
Accrued compensation -
officer
$417,470
Due to related
parties
$224,802
Prepaid expenses
-$3,183
Net cash used in
operating activities
-$3,688,188
Canceled cashflow
$6,775,784
Net loss
-$10,413,205
Trade accounts
payable and accrued...
-$50,767
Back
Back
Cash Flow
source: myfinsight.com
Telomir Pharmaceuticals, Inc. (TELO)
Telomir Pharmaceuticals, Inc. (TELO)